PharmacyCodes



Monobenzona [INN-Spanish] en es it fr

Monobenzona [INN-Spanish] Brand names, Monobenzona [INN-Spanish] Analogs

Monobenzona [INN-Spanish] Brand Names Mixture

  • No information avaliable

Monobenzona [INN-Spanish] Chemical_Formula

C21H22N2O5S

Monobenzona [INN-Spanish] RX_link

http://www.rxlist.com/cgi/generic3/nafcillin.htm

Monobenzona [INN-Spanish] fda sheet

Monobenzona [INN-Spanish] msds (material safety sheet)

Monobenzona_[INN-Spanish] MSDS

Monobenzona [INN-Spanish] Synthesis Reference

No information avaliable

Monobenzona [INN-Spanish] Molecular Weight

414.476 g/mol

Monobenzona [INN-Spanish] Melting Point

No information avaliable

Monobenzona [INN-Spanish] H2O Solubility

Soluble

Monobenzona [INN-Spanish] State

Solid

Monobenzona [INN-Spanish] LogP

3.373

Monobenzona [INN-Spanish] Dosage Forms

Powder for solution

Monobenzona [INN-Spanish] Indication

For the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drugs.

Monobenzona [INN-Spanish] Pharmacology

Nafcillin is a semisynthetic antibiotic substance derived from 6-amino-penicillanic acid. The drugs in this class are highly resistant to inactivation by staphylococcal penicillinase and are active against penicillinase-producing and non penicillinase-producing strains of Staphylococcus aureus. The penicillinase- resistant penicillins are active in vitro against a variety of other bacteria.

Monobenzona [INN-Spanish] Absorption

No information avaliable

Monobenzona [INN-Spanish] side effects and Toxicity

Serious toxicity is unlikely following large doses of nafcillin. Acute ingestion of large doses of nafcillin may cause nausea, vomiting, diarrhea and abdominal pain. Acute oliguric renal failure and hematuria may occur following large doses.

Monobenzona [INN-Spanish] Patient Information

Monobenzona [INN-Spanish] Organisms Affected

Enteric bacteria and other eubacteria